Article

Preclinical PET Characterization of [68Ga]Ga-EMP-100 for Non-Invasive Assessment of c-Met in NSCLC

2026-03-11

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> The c-Met receptor is a key therapeutic target in non-small cell lung cancer (NSCLC). Current methods for assessing c-Met level, are limited by biopsy sampling, which fails to account for spatio temporal and intra-tumour heterogeneity. This study aims to evaluate the use of PET/CT imaging for non-invasive, full-body quantification of c-Met expression in differ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d37cf8a-3d1a-5a32-b044-f76a769ddf06
DOI: 10.21203/rs.3.rs-8970902/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest

Preclinical PET Characterization of [68Ga]Ga-EMP-100 for Non-Invasive Assessment of c-Met in NSCLCDOI 10.21203/rs.3.rs-8970902/v1Read

Preclinical Evaluation of 68Ga-Labeled SL1 Aptamer for c-Met Targeted PET ImagingSemantic proximity Read

A 68Ga–BCMA Ectodomain Tracer Enables PET/MR Longitudinal Tracking of Clinical-Grade BCMA/CD19 CAR T CellsSemantic proximity Read

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.Semantic proximity Read

Preclinical and Exploratory Clinical Studies of Novel 68Ga-labeled ᴅ-Peptide Antagonist for PET Imaging of TIGIT Expression in CancersSemantic proximity Read

PET imaging reveals EGFR mutation status.Semantic proximity Read

Understanding c-MET signalling in squamous cell carcinoma of the head & neckSemantic proximity Read

A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management.Semantic proximity Read

Consistency of c-Met protein overexpression over time in patients with non-squamous non-small cell lung cancer.Semantic proximity Read

PET and SPECT Imaging of the EGFR Family (RTK Class I) in OncologySemantic proximity Read

Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?Semantic proximity Read

Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells.Semantic proximity Read